Literature DB >> 11700959

Effect of chronic manganese treatment on adenosine tissue levels and adenosine A2a receptor binding in diverse regions of mouse brain.

V Villalobos1, J Suárez, J Estévez, E Novo, E Bonilla.   

Abstract

In the present study the effects of chronic manganese (Mn) treatment on adenosine A2a receptor binding in mouse brain have been assessed. Male albino mice were divided in two groups: In the Mn-treated group, the animals were injected intraperitoneally (i.p.) with MnCl2 (5 mg/kg/day) five days per week during 9 weeks; in the control group, they were injected likewise with a saline solution. A significant decrease of the Kd without alteration of Bmax in the cerebellum and, an increase of the Kd and Bmax in hippocampus of mice treated with Mn were found. Also, an increase of Kd in frontal cortex was observed. The binding parameters in caudate nucleus, olfactory bulb and hypothalamus were not altered by Mn. A significant decrease in the adenosine concentration in caudate nucleus, olfactory bulb and hypothalamus, without significant changes in hippocampus, frontal cortex and cerebellum was also detected. These findings suggest that chronic administration of Mn could affect adenosine receptor function and turnover, depending on the brain region analyzed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700959     DOI: 10.1023/a:1012379024571

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Stimulation of adenosine A2 receptors induces catalepsy.

Authors:  S Ferré; A Rubio; K Fuxe
Journal:  Neurosci Lett       Date:  1991-09-16       Impact factor: 3.046

2.  Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

Authors:  S N Schiffmann; O Jacobs; J J Vanderhaeghen
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

Review 3.  A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system.

Authors:  S Latini; M Pazzagli; G Pepeu; F Pedata
Journal:  Gen Pharmacol       Date:  1996-09

4.  Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680.

Authors:  M F Jarvis; M Williams
Journal:  Eur J Pharmacol       Date:  1989-09-13       Impact factor: 4.432

Review 5.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

6.  Flameless atomic absorption spectrophotometric determination of manganese in rat brain and other tissues.

Authors:  E Bonilla
Journal:  Clin Chem       Date:  1978-03       Impact factor: 8.327

7.  Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).

Authors:  A Barbeau
Journal:  Neurotoxicology       Date:  1984       Impact factor: 4.294

8.  Effect of manganese on synthesis of brain catecholamines in growing rats.

Authors:  S V Chandra; G S Shukla
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-04

9.  The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum.

Authors:  B Johansson; V Georgiev; F E Parkinson; B B Fredholm
Journal:  Eur J Pharmacol       Date:  1993-10-15       Impact factor: 4.432

10.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.

Authors:  S Ferré; M Herrera-Marschitz; M Grabowska-Andén; M Casas; U Ungerstedt; N E Andén
Journal:  Eur J Pharmacol       Date:  1991-01-03       Impact factor: 4.432

View more
  1 in total

1.  Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats.

Authors:  Katharina Neth; Marianna Lucio; Alesia Walker; Julia Zorn; Philippe Schmitt-Kopplin; Bernhard Michalke
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.